Navigation Links
Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation

oducing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.


Daiichi Sankyo Co., Ltd.

3-5-1, Nihonbashi Honcho, Chuo-ku,

Tokyo 103-8426, Japan

Masaya Tamae

Director-Public Relations Group, Corporate Communications Department

Tel: +81-3-6225-1126


Plot 90, Sector 32, Gurgaon

Haryana122001, India

Ramesh L. Adige

Executive Director-Corporate Affairs and Global Corporate Communications


Tel: +91-124-4135000


Raghu Kochar

Director-Corporate Communications


Tel: +91-124-4135141

Mobile: 9811617256


Krishnan Ramalingam

Sr. Manager-Corporate Communications


Tel: +91-124-4135143

Mobile: 9810042540

SOURCE Daiichi Sankyo Company, Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
2. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
3. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
4. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
5. Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
6. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
8. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
9. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
10. Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol
11. ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
Post Your Comments:
(Date:10/8/2015)... the Wyss Institute for Biologically Inspired Engineering at Harvard ... Opsonix Inc. The announcement follows a worldwide exclusive ... (OTD) and Opsonix Inc. enabling the company to ... --> --> Pathogen-induced ... in the U.S. — more than prostate cancer, breast ...
(Date:10/8/2015)... ... 2015 , ... ProMIS Neurosciences, Inc. (TSX: PMN), announced today ... intellectual property rights belonging to The University of British Columbia (UBC). This agreement ... rights to intellectual property based on use of the ProMIS™ technology, modifications and ...
(Date:10/7/2015)... Mass. , Oct. 7, 2015 ... announced the start of the Boston Scientific Connected ... encourage advancements in the use of remote patient monitoring ... engineers, designers and entrepreneurs can submit their ideas and ... site ( ). Cambridge, MA ...
(Date:10/7/2015)... 7, 2015  ChromaDex Corp. (OTCQX: CDXC), an ... that creates science-based solutions for dietary supplement, food ... products, today announced that the October 1 presentation ... is now available for on-demand viewing at ...   --> LINK: ...
Breaking Biology Technology:
... NVAX ) today announced that it will report its ... be issued after 8:00 a.m. Eastern Time on Friday, May ... to discuss its financial results at 10:00 a.m. Eastern Time ... by Novavax President and Chief Executive Officer Dr. Rahul Singhvi ...
... Meso Scale Diagnostics, LLC. (MSD) confirmed today that ... first identified case of infection with the 2009 A(H1N1) ... Test, which is being developed under a contract with ... the investigational device referred to in the CDC,s Morbidity ...
... Group Inc. (OTC Bulletin Board: BMSN)( ... owned subsidiary, announced today they have jointly submitted a ... and Materiel Command (USAMRMC) for consideration of funding to ... harvested from liposuction for treating Traumatic Brain Injury (TBI). ...
Cached Biology Technology:
(Date:9/10/2015)... 2015 This report provides detailed descriptions of ... and emerging sensor types that will dominate in the ... of the wearable technology hype curve in the last ... common feature with all of them is the prominence ... most useful functions. Sensors collect data about the physical ...
(Date:9/10/2015)... 2015 Pursuant Health has collaborated with ... an interactive, image-based health risk assessment (HRA) optimized ... The unique assessment quantifies user results into an ... an individual,s biological age based on personal health ... the kiosk. Comprised of age, gender, ...
(Date:9/8/2015)... --  TREW Marketing and today ... for Engineers TM : Content and Online Marketing . ... about engineers, preferences for online content marketing and channels ... and trust, and where they look for that content ... with how to best implement online and content marketing ...
Breaking Biology News(10 mins):
... from livestock infected with foot and mouth disease could very ... in the Proceedings of the Royal Society B , ... skin cells could be a source of infectious foot and ... facts that foot and mouth disease virus is found in ...
... Similar to humans, the bacteria and tiny plants living ... their situation is quite different than ours for one, ... greens or red meat for a pick-me-up. So where ... Nature Geoscience " points to a source on the seafloor: ...
... assumed that wild animals died before they got old. Now, ... ageing in a population of wild birds ( Sula nebouxii ... "It was always thought that senescence was something particular ... life expectancy", Alberto Velando, lead author of the study and ...
Cached Biology News:
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Biology Products: